Cargando…
A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
Tumor escape from immune-mediated destruction has been associated with immunosuppressive mechanisms that inhibit T-cell activation. A promising strategy for cancer immunotherapy is to disrupt key pathways regulating immune tolerance, such as program death-1 (PD-1/PD-L1) pathway in the tumor environm...
Autores principales: | Tian, Hongwei, Shi, Gang, Wang, Qin, Li, Yiming, Yang, Qianmei, Li, Chunlei, Yang, Guoyou, Wu, Min, Xie, Qian, Zhang, Shuang, Yang, Yang, Xiang, Rong, Yu, Dechao, Wei, Yuquan, Deng, Hongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661645/ https://www.ncbi.nlm.nih.gov/pubmed/29263903 http://dx.doi.org/10.1038/sigtrans.2016.25 |
Ejemplares similares
-
Author Correction: A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
por: Tian, Hongwei, et al.
Publicado: (2019) -
Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects
por: Tian, Hongwei, et al.
Publicado: (2014) -
Correction to: Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects
por: Tian, Hongwei, et al.
Publicado: (2020) -
Retraction Note: Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects
por: Tian, Hongwei, et al.
Publicado: (2023) -
A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b
por: Wang, Huiling, et al.
Publicado: (2019)